Overview

• Decree 515/5025, signed by President Javier Milei and Luis Caputo, formalized María Beatriz “Pilu” Giraudo’s elevation to SENASA president effective July 29, 2025.
• Giraudo succeeds Pablo Cortese, who resigned on July 28 citing personal reasons after a high-stakes dispute over the approval of 8,300 doses of the Brazilian Ourovac aftosa vaccine.
• An agronomist with experience as INTA vice president and Aapresid leader, Giraudo inherits a mandate to cut vaccine costs and streamline import procedures.
• Veterinary industry groups including Biogénesis Bagó and Caprove warn that relaxed import requirements could weaken local lab competitiveness and undermine regional biosecurity measures such as the Patagonia barrier.
• The Milei administration maintains that deregulating the veterinary vaccine market will lower prices by roughly half and boost supply options for Argentina’s livestock sector.